Neurogene Inc. Share Price
NGNE$0.00
+0.00 (0.00%) Neurogene Inc. Stock Performance
Open N/A | Prev. Close N/A | Circuit Range N/A |
Day Range N/A | Year Range N/A | Volume N/A |
Average Traded N/A |
Neurogene Inc. Share Price Chart
$0.00
Please wait...
About Neurogene Inc.
Neurogene Inc., a clinical stage biotechnology company, develops genetic medicines for rare neurological diseases. The company's product candidates include NGN-401 that is packaged in an adeno-associated virus 9, which is in Phase 1/2 clinical trial for the treatment of Rett syndrome; and NGN-101, a conventional gene therapy candidate that is in Phase 1/2 clinical trial to treat CLN5 Batten disease. It has a license agreements with The University of Edinburgh, Virovek, Inc., Sigma-Aldrich Co. LLC., and Leland Stanford Junior University. The company was founded in 2018 and is headquartered in New York, New York.
Neurogene Inc. Historical Data
| Day | Open | Close | Change % |
|---|
FAQs on Neurogene Inc. Share Price
Can I buy Neurogene Inc. shares in India?
Yes. You can buy Neurogene Inc. in India by opening an international trading account.
What is the share price of Neurogene Inc.?
As on 01 Mar '26, the share price of Neurogene Inc. NGNE is $0.00. If you are investing from India, it is a good idea to check the current exchange rate and calculate the value in rupees before making your investment.
What is the 5 year returns of Neurogene Inc.?
The 5 year returns of Neurogene Inc. is as on 01 Mar '26.
What are the high & low stock price of Neurogene Inc. today?
Neurogene Inc. stock price hit a high of $0.00 and low of $0.00 as on 01 Mar '26.
What is the 52-week high and low of Neurogene Inc. stock?
The 52-week high of Neurogene Inc. stock is $0.00, while the 52-week low is $0.00 as on 01 Mar '26.